Evelien Moorkens Arnold G Vulto Isabelle Huys
10.1080/19420862.2020.1743517
MAbs
2020 Jan-Dec;12(1):1743517.
intellectual property strategies biopharmaceutical market biosimilars monoclonal antibodies patents
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/32306833/
Antibodies, Monoclonal / therapeutic use Biosimilar Pharmaceuticals / therapeutic use Drug Approval / statistics & numerical data Drug Industry / statistics & numerical data
Antibodies, Monoclonal / therapeutic use Biosimilar Pharmaceuticals / therapeutic use Drug Approval / statistics & numerical data Drug Industry / statistics & numerical data Research Support, Non-U.S. Gov't Review Antineoplastic Agents, Immunological / therapeutic use Bevacizumab / therapeutic use Drug Approval / legislation & jurisprudence Drug Industry / economics Drug Industry / trends Europe Humans Rituximab / therapeutic use Trastuzumab / therapeutic use Antibodies, Monoclonal Antineoplastic Agents, Immunological Biosimilar Pharmaceuticals Bevacizumab Rituximab Trastuzumab
PMC7188399
32306833
An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?
2020